miR-31-5p as a Potential Circulating Biomarker and Tracer of Clinical Improvement for Chronic Inflammatory Demyelinating Polyneuropathy

Figure 2

Scatter plot of the correlation between miR-31-5p expression and IgIV treatment time in CIDP patients.